Nalmefene Completed Phase 4 Trials for Alcohol Dependency Treatment

IndicationsStatusPurposePhase
CompletedTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT02197598Treatment of Patients Suffering of Alcohol Dependence and Impaired Liver Function With Selincro® As-needed Use